6 курс / Гастроэнтерология / Эволюция_представлений_о_синдроме_раздраженного_кишечника_Маев_И

ЭВОЛЮЦИЯ ПРЕДСТАВЛЕНИЙ О СИНДРОМЕ РАЗДРАЖЕННОГО КИШЕЧНИКА

23.Scarpellini E. et al. Efficacy of butyrate in the treatment of diarrhoea-predominant irritable bowel syndrome. Dig Liver Dis. 2007; Suppl. 1: 19-22.

24.Soret, R., et al., Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology, 2010. 138 (5): P. 1772–82.

25.Spiller RC, Jenkins D, Thornley JP. et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47(6):804-11..

26.Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol. 2007;42:41-7.

27.Talley N.J., Weaver A.I., Zinsmeister A.R., Melton L.I. Onset and disappearence of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidimiol 1992; 136: 165-177.

28.Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. – In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. The functional gastrointestinal disorders. 2nd ed. Washington: Degnon, 2000.

29.World Gastroenterology Organization. Global Guideline. Irritable bowel syndrome: a global perspective. 2009.

80